{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:37:25Z","timestamp":1782283045045,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-022-00866-5","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T14:02:33Z","timestamp":1660226553000},"page":"803-813","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases"],"prefix":"10.1007","volume":"23","author":[{"given":"Vincent","family":"Jachiet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Ricard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Malard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Pascal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Beyne-Rauzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Peterlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Thibault Jacques","family":"Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Vey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"D\u2019Aveni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Gourin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dimicoli-Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Banos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Wickenhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Terriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"De Renzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Durot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanti","family":"Natarajan-Ame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Vekhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Voillat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Vinit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Dieval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeddine","family":"Dellal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Grobost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Solary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Kosmider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Dulphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin Pierre","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Ad\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Fenaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Fain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Gaugler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ars\u00e8ne","family":"Mekinian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"MINHEMON: French Network of dysimmune disorders associated with hemopathies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"866_CR1","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(13)61901-7","volume":"383","author":"L Ad\u00e8s","year":"2014","unstructured":"Ad\u00e8s L, Itzykson R, Fenaux P. Myelodysplastic syndromes. Lancet. 2014;383:2239\u201352.","journal-title":"Lancet"},{"key":"866_CR2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2009.07593.x","volume":"145","author":"SY Kordasti","year":"2009","unstructured":"Kordasti SY, et al. IL-17-producing CD4+T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome. Br J Haematol. 2009;145:64\u201372.","journal-title":"Br J Haematol"},{"key":"866_CR3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.clim.2011.03.001","volume":"139","author":"I Bouchliou","year":"2011","unstructured":"Bouchliou I, et al. Th17 and Foxp3+ T regulatory cell dynamics and distribution in myelodysplastic syndromes. Clin Immunol. 2011;139:350\u20139.","journal-title":"Clin Immunol"},{"key":"866_CR4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1182\/blood-2007-01-067546","volume":"110","author":"SY Kordasti","year":"2007","unstructured":"Kordasti SY, et al. CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS). Blood. 2007;110:847\u201350.","journal-title":"Blood"},{"key":"866_CR5","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/leu.2008.333","volume":"23","author":"I Kotsianidis","year":"2009","unstructured":"Kotsianidis I, et al. Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS). Leukemia. 2009;23:510\u20138.","journal-title":"Leukemia"},{"key":"866_CR6","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1062208","volume":"5","author":"AO Kittang","year":"2016","unstructured":"Kittang AO, et al. Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome. Oncoimmunology. 2016;5: e1062208.","journal-title":"Oncoimmunology"},{"key":"866_CR7","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00277-018-3472-9","volume":"97","author":"E Grignano","year":"2018","unstructured":"Grignano E, et al. Autoimmune manifestations associated with myelodysplastic syndromes. Ann Hematol. 2018;97:2015\u201323.","journal-title":"Ann Hematol"},{"key":"866_CR8","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","volume":"383","author":"DB Beck","year":"2020","unstructured":"Beck DB, et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med. 2020;383:2628\u201338.","journal-title":"N Engl J Med"},{"key":"866_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20805","author":"S Georgin-Lavialle","year":"2021","unstructured":"Georgin-Lavialle S, et al. Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients. Br J Dermatol. 2021. https:\/\/doi.org\/10.1111\/bjd.20805.","journal-title":"Br J Dermatol"},{"key":"866_CR10","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1084\/jem.20161135","volume":"213","author":"G Breton","year":"2016","unstructured":"Breton G, et al. Human dendritic cells (DCs) are derived from distinct circulating precursors that are precommitted to become CD1c+ or CD141+ DCs. J Exp Med. 2016;213:2861\u201370.","journal-title":"J Exp Med"},{"key":"866_CR11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1084\/jem.20141441","volume":"212","author":"G Breton","year":"2015","unstructured":"Breton G, et al. Circulating precursors of human CD1c+ and CD141+ dendritic cells. J Exp Med. 2015;212:401\u201313.","journal-title":"J Exp Med"},{"key":"866_CR12","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/ni.3200","volume":"16","author":"A Schlitzer","year":"2015","unstructured":"Schlitzer A, et al. Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow. Nat Immunol. 2015;16:718\u201328.","journal-title":"Nat Immunol"},{"key":"866_CR13","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.4049\/jimmunol.165.11.6037","volume":"165","author":"A Dzionek","year":"2000","unstructured":"Dzionek A, et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol. 2000;165:6037\u201346.","journal-title":"J Immunol"},{"key":"866_CR14","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1182\/blood-2001-11-0097","volume":"100","author":"KPA MacDonald","year":"2002","unstructured":"MacDonald KPA, et al. Characterization of human blood dendritic cell subsets. Blood. 2002;100:4512\u201320.","journal-title":"Blood"},{"key":"866_CR15","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1186\/gb-2008-9-1-r17","volume":"9","author":"SH Robbins","year":"2008","unstructured":"Robbins SH, et al. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol. 2008;9:R17.","journal-title":"Genome Biol"},{"key":"866_CR16","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","volume":"116","author":"L Ziegler-Heitbrock","year":"2010","unstructured":"Ziegler-Heitbrock L, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116:e74\u201380.","journal-title":"Blood"},{"key":"866_CR17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.immuni.2010.08.012","volume":"33","author":"J Cros","year":"2010","unstructured":"Cros J, et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity. 2010;33:375\u201386.","journal-title":"Immunity"},{"key":"866_CR18","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1182\/blood-2010-12-326355","volume":"118","author":"KL Wong","year":"2011","unstructured":"Wong KL, et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood. 2011;118:e16\u201331.","journal-title":"Blood"},{"key":"866_CR19","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1182\/blood-2011-01-326827","volume":"118","author":"AM Zawada","year":"2011","unstructured":"Zawada AM, et al. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood. 2011;118:e50\u201361.","journal-title":"Blood"},{"key":"866_CR20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.immuni.2006.03.020","volume":"24","author":"K Sch\u00e4kel","year":"2006","unstructured":"Sch\u00e4kel K, et al. Human 6-Sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes. Immunity. 2006;24:767\u201377.","journal-title":"Immunity"},{"key":"866_CR21","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4084::AID-IMMU4084>3.0.CO;2-4","volume":"28","author":"K Sch\u00e4kel","year":"1998","unstructured":"Sch\u00e4kel K, et al. A novel dendritic cell population in human blood: one-step immunomagnetic isolation by a specific mAb (M-DC8) and in vitro priming of cytotoxic T lymphocytes. Eur J Immunol. 1998;28:4084\u201393.","journal-title":"Eur J Immunol"},{"key":"866_CR22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1074-7613(02)00393-X","volume":"17","author":"K Sch\u00e4kel","year":"2002","unstructured":"Sch\u00e4kel K, et al. 6-Sulfo LacNAc, a novel carbohydrate modification of PSGL-1, defines an inflammatory type of human dendritic cells. Immunity. 2002;17:289\u2013301.","journal-title":"Immunity"},{"key":"866_CR23","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3389\/fimmu.2018.01619","volume":"9","author":"N van Leeuwen-Kerkhoff","year":"2018","unstructured":"van Leeuwen-Kerkhoff N, et al. Human bone marrow-derived myeloid dendritic cells show an immature transcriptional and functional profile compared to their peripheral blood counterparts and separate from slan+ non-classical monocytes. Front Immunol. 2018;9:1619.","journal-title":"Front Immunol"},{"key":"866_CR24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1189\/jlb.3MA0117-037R","volume":"102","author":"N van Leeuwen-Kerkhoff","year":"2017","unstructured":"van Leeuwen-Kerkhoff N, et al. Transcriptional profiling reveals functional dichotomy between human Slan+non-classical monocytes and myeloid dendritic cells. J Leukoc Biol. 2017;102:1055\u201368.","journal-title":"J Leukoc Biol"},{"key":"866_CR25","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood-2015-06-651331","volume":"126","author":"TP Hofer","year":"2015","unstructured":"Hofer TP, et al. slan-defined subsets of CD16-positive monocytes: impact of granulomatous inflammation and M-CSF receptor mutation. Blood. 2015;126:2601\u201310.","journal-title":"Blood"},{"key":"866_CR26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.beha.2013.09.003","volume":"26","author":"T Braun","year":"2013","unstructured":"Braun T, Fenaux P. Myelodysplastic syndromes (MDS) and autoimmune disorders (AD): cause or consequence? Best Pract Res Clin Haematol. 2013;26:327\u201336.","journal-title":"Best Pract Res Clin Haematol"},{"key":"866_CR27","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood-2018-10-844654","volume":"133","author":"DA Sallman","year":"2019","unstructured":"Sallman DA, List A. The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes. Blood. 2019;133:1039\u201348.","journal-title":"Blood"},{"key":"866_CR28","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1038\/s41375-021-01152-1","volume":"35","author":"LP Zhao","year":"2021","unstructured":"Zhao LP, et al. Genomic landscape of MDS\/CMML associated with systemic inflammatory and autoimmune disease. Leukemia. 2021;35:2720\u20134.","journal-title":"Leukemia"},{"key":"866_CR29","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.268136","author":"N Van Leeuwen-Kerkhoff","year":"2021","unstructured":"Van Leeuwen-Kerkhoff N, et al. Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes. Haematologica. 2021. https:\/\/doi.org\/10.3324\/haematol.2020.268136.","journal-title":"Haematologica"},{"key":"866_CR30","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0198-8859(02)00756-5","volume":"63","author":"MA Gill","year":"2002","unstructured":"Gill MA, et al. Blood dendritic cells and DC-poietins in systemic lupus erythematosus. Hum Immunol. 2002;63:1172\u201380.","journal-title":"Hum Immunol"},{"key":"866_CR31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/09511920410001713538","volume":"13","author":"E Robak","year":"2004","unstructured":"Robak E, Smolewski P, Wo\u017aniacka A, Sysa-Jedrzejowska A, Robak T. Clinical significance of circulating dendritic cells in patients with systemic lupus erythematosus. Mediat Inflamm. 2004;13:171\u201380.","journal-title":"Mediat Inflamm"},{"key":"866_CR32","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/1529-0131(200104)44:4<856::AID-ANR142>3.0.CO;2-A","volume":"44","author":"C Scheinecker","year":"2001","unstructured":"Scheinecker C, Zwlfer B, Kller M, Mnner G, Smolen JS. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies. Arthritis Rheum. 2001;44:856\u201365.","journal-title":"Arthritis Rheum"},{"key":"866_CR33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-2249.2005.02897.x","volume":"142","author":"K Migita","year":"2005","unstructured":"Migita K, et al. Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus. Clin Exp Immunol. 2005;142:84\u201391.","journal-title":"Clin Exp Immunol"},{"key":"866_CR34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.molimm.2007.04.029","volume":"45","author":"N Fiore","year":"2008","unstructured":"Fiore N, et al. Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis. Mol Immunol. 2008;45:259\u201365.","journal-title":"Mol Immunol"},{"key":"866_CR35","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1177\/0961203308089410","volume":"17","author":"O Jin","year":"2008","unstructured":"Jin O, et al. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression. Lupus. 2008;17:654\u201362.","journal-title":"Lupus"},{"key":"866_CR36","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00296-010-1709-6","volume":"32","author":"A Henriques","year":"2012","unstructured":"Henriques A, et al. Functional characterization of peripheral blood dendritic cells and monocytes in systemic lupus erythematosus. Rheumatol Int. 2012;32:863\u20139.","journal-title":"Rheumatol Int"},{"key":"866_CR37","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1136\/ard.2009.111021","volume":"69","author":"V Gerl","year":"2010","unstructured":"Gerl V, et al. Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function. Ann Rheum Dis. 2010;69:1370\u20137.","journal-title":"Ann Rheum Dis"},{"key":"866_CR38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/art.23186","volume":"58","author":"M Tucci","year":"2008","unstructured":"Tucci M, et al. Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18. Arthritis Rheum. 2008;58:251\u201362.","journal-title":"Arthritis Rheum"},{"key":"866_CR39","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96492","volume":"3","author":"F Olaru","year":"2018","unstructured":"Olaru F, et al. Intracapillary immune complexes recruit and activate slan-expressing CD16+ monocytes in human lupus nephritis. JCI Insight. 2018;3: e96492.","journal-title":"JCI Insight"},{"key":"866_CR40","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jamadermatol.2021.3344","volume":"157","author":"E Zakine","year":"2021","unstructured":"Zakine E, et al. UBA1 variations in neutrophilic dermatosis skin lesions of patients with VEXAS syndrome. JAMA Dermatol. 2021;157:1349\u201354.","journal-title":"JAMA Dermatol"},{"key":"866_CR41","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1182\/blood-2021-150904","volume":"138","author":"A M\u00e9kinian","year":"2021","unstructured":"M\u00e9kinian A, et al. A phase II study of the efficacy and tolerance of azacytidine (AZA) in steroid dependent\/refractory systemic autoimmune and inflammatory disorders (SAID) associated with MDS or CMML (GFM- AZA-SAID -trial). Blood. 2021;138:3697.","journal-title":"Blood"},{"key":"866_CR42","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391\u2013405.","journal-title":"Blood"},{"key":"866_CR43","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","volume":"120","author":"PL Greenberg","year":"2012","unstructured":"Greenberg PL, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120:2454\u201365.","journal-title":"Blood"},{"key":"866_CR44","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood-2016-02-700054","volume":"128","author":"M Pfeilst\u00f6cker","year":"2016","unstructured":"Pfeilst\u00f6cker M, et al. Time-dependent changes in mortality and transformation risk in MDS. Blood. 2016;128:902\u201310.","journal-title":"Blood"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00866-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-022-00866-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00866-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T10:15:44Z","timestamp":1687342544000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-022-00866-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["866"],"URL":"https:\/\/doi.org\/10.1007\/s10238-022-00866-5","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,11]]},"assertion":[{"value":"10 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AM is investigator of CELGENE, ROCHE, CHUGAI founded trials with APHP and Hopital 15\u201320 promotion; AM received several fees for congress travels and experts\u2019 use from LFB, SANOFI, SHIRE, and CELGENE. The other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All participants provided written informed consent. The study was approved by the local institutional review board (EudraCT 2016-000918-30, ANSM (Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament) 160580A-11, registration date 26-AUG-2016) and in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}